Stock 4551 TORII PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Torii Pharmaceutical Co., Ltd.

Equities

4551

JP3635800000

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
3,855 JPY +1.72% Intraday chart for Torii Pharmaceutical Co., Ltd. +4.47% +8.44%
Feb. 13 LIM Advisors Partially Withdraws Shareholder Proposal CI
Feb. 09 Torii Pharmaceuticals Opposes Shareholder Proposal CI

Business Summary

TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Number of employees: 583

Sales per Business

JPY in Million2022Weight2023Weight Delta
Finished Goods
53.8 %
25,933 53.0 % 29,378 53.8 % +13.28%
Pharmaceutical Products
45.7 %
22,629 46.3 % 24,960 45.7 % +10.30%
Other
0.5 %
332 0.7 % 299 0.5 % -9.94%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
48,896 100.0 % 54,638 100.0 % +11.74%

Managers

Managers TitleAgeSince
Goichi Matsuda PSD
 President 57 17-02-28
Yukihiro Takashima DFI
 Director of Finance/CFO - -
Megumi Kajiwara CTO
 Chief Tech/Sci/R&D Officer - -
Toshio Fukuoka BRD
 Director/Board Member 70 16-02-29
Masao Torikai BRD
 Director/Board Member 61 10-05-31
Ken Yamamoto AUD
 Comptroller/Controller/Auditor 58 16-02-29
Atsuyuki Kakee PRN
 Corporate Officer/Principal 60 14-12-31
Masaki Sunami PRN
 Corporate Officer/Principal 65 14-03-31
Katsunobu Fujiwara PRN
 Corporate Officer/Principal 60 87-03-31

Members of the board

Members of the board TitleAgeSince
Katsunobu Fujiwara PRN
 Corporate Officer/Principal 60 87-03-31
Masao Torikai BRD
 Director/Board Member 61 10-05-31
Masaki Sunami PRN
 Corporate Officer/Principal 65 14-03-31
Atsuyuki Kakee PRN
 Corporate Officer/Principal 60 14-12-31
Goichi Matsuda PSD
 President 57 17-02-28
Toshio Fukuoka BRD
 Director/Board Member 70 16-02-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 28,800,000 12,145,840 ( 42.17 %) 694,854 ( 2.413 %) 42.17 %

Shareholders

NameEquities%Valuation
JAPAN TOBACCO, INC.
53.47 %
15,398,800 53.47 % 417 M ¥
TORII PHARMACEUTICAL CO., LTD.
2.412 %
694,600 2.412 % 19 M ¥
Effissimo Capital Management Pte Ltd.
2.042 %
588,200 2.042 % 16 M ¥
Torii Pharmaceutical Employee Stock Ownership Plan
0.8201 %
236,200 0.8201 % 6 M ¥
Andbank Asset Management Luxembourg SA
0.7424 %
213,800 0.7424 % 6 M ¥
MEDIPAL HOLDINGS CORPORATION
0.5868 %
168,988 0.5868 % 5 M ¥
SUZUKEN CO., LTD.
0.4104 %
118,200 0.4104 % 3 M ¥
Beagle Asset Management AG
0.3819 %
110,000 0.3819 % 3 M ¥
VITAL KSK HOLDINGS, INC.
0.1943 %
55,956 0.1943 % 2 M ¥
Torii Pharmaceutical Restricted Stock Compensation Plan
0.1935 %
55,741 0.1935 % 2 M ¥

Holdings

NameEquities%Valuation
TORII PHARMACEUTICAL CO., LTD.
2.41%
 694,600 2.41% 18,794,063 $
MEDIPAL HOLDINGS CORPORATION
0.10%
 221,746 0.10% 3,399,191 $
SUZUKEN CO., LTD.
0.14%
 106,768 0.14% 3,272,634 $
VITAL KSK HOLDINGS, INC.
0.08%
 44,058 0.08% 365,634 $
HOKUYAKU TAKEYAMA HOLDINGS,INC.
0.08%
 19,368 0.08% 111,336 $

Company contact information

Torii Pharmaceutical Co., Ltd.

Torii Nihonbashi Building 3-4-1 Nihonbashi-Honcho

103-8439, Tokyo

+

http://www.torii.co.jp
address Torii Pharmaceutical Co., Ltd.(4551)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Torii Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TORII PHARMACEUTICAL CO., LTD. Stock Torii Pharmaceutical Co., Ltd.
+8.44% 688M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4551 Stock
  4. Company Torii Pharmaceutical Co., Ltd.